PI3K/AKT/mTOR通路
蛋白激酶B
癌症研究
生物
转录组
下调和上调
癌症
信号转导
基因
遗传学
基因表达
作者
Ying Jin,Yamei Chen,Huarong Tang,Xiao Hu,Shawna M. Hubert,Qian Li,Dan Su,Haimiao Xu,Yun Fan,Xinmin Yu,Qixun Chen,Jinshi Liu,Wei Hong,Yujin Xu,Huan Deng,Dapeng Zhu,Pansong Li,Yuhua Gong,Xuefeng Xia,Carl M. Gay
标识
DOI：10.1158/1078-0432.ccr-21-1943
摘要
PI3K/AKT pathway activation may be one potential mechanism underlying therapeutic resistance of SCLC. This finding warrants further investigation and provides a possible approach to reverse resistance to chemo/radiotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
cdercder
嘻嘻哈哈
Copyright
OK
无情的聪健
arniu2008
Jessy畅畅
lizishu
Nole
liuzhuohao
Samuel
yjh123
行走的荷尔蒙
研友_ZbM2qn
Oracle
pluto
sagitar
路豐遙
乐空思
皖公网安备34019202002308
